BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

752 related articles for article (PubMed ID: 15877788)

  • 1. The use of low dose octreotide prophylaxis in pancreatic transplants with enteric drainage. Results of a prospective randomized single center trial.
    Hesse UJ; Meester D; Troisi R; Cathenis K; Lameire N; Hemptinne B
    Clin Transplant; 2005 Jun; 19(3):299-303. PubMed ID: 15877788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectrum of surgical complications after simultaneous pancreas-kidney transplantation in a prospectively randomized study of two immunosuppressive protocols.
    Steurer W; Malaise J; Mark W; Koenigsrainer A; Margreiter R;
    Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii54-62. PubMed ID: 15814551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Octreotide in the prevention of intra-abdominal complications following elective pancreatic resection: a prospective, multicenter randomized controlled trial.
    Suc B; Msika S; Piccinini M; Fourtanier G; Hay JM; Flamant Y; Fingerhut A; Fagniez PL; Chipponi J;
    Arch Surg; 2004 Mar; 139(3):288-94; discussion 295. PubMed ID: 15006886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late anastomotic leaks in pancreas transplant recipients - clinical characteristics and predisposing factors.
    Nath DS; Gruessner A; Kandaswamy R; Gruessner RW; Sutherland DE; Humar A
    Clin Transplant; 2005 Apr; 19(2):220-4. PubMed ID: 15740558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreas transplantation: advantages of both enteric and bladder drainage combined in a two-step approach.
    van de Linde P; van der Boog PJ; Baranski AG; de Fijter JW; Ringers J; Schaapherder AF
    Clin Transplant; 2006; 20(2):253-7. PubMed ID: 16640535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Octreotide inhibits pancreatic exocrine secretion and prevents pancreatoenterostomy leakage.
    Nakatsuka A; Yamaguchi K; Chijiiwa K; Tanaka M
    Int Surg; 2000; 85(2):124-9. PubMed ID: 11071328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors of pancreatic fistula following pancreaticoduodenectomy for periampullary cancer.
    Popiela T; Kedra B; Sierzega M; Gurda A
    Hepatogastroenterology; 2004; 51(59):1484-8. PubMed ID: 15362783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of desmopressin and vasopressors in the donor management on graft function following pancreas transplantation.
    Decraemer I; Cathenis K; Troisi R; deHemptinne B; Hesse UJ
    Transplant Proc; 2004 May; 36(4):1042-4. PubMed ID: 15194362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prospective and randomized study on the usefulness of octreotide in the prevention of complications after cephalic duodeno-pancreatectomy].
    Briceño Delgado FJ; López Cillero P; Rufián Peña S; Solórzano Peck G; Miño Fugarolas G; Pera Madrazo C
    Rev Esp Enferm Dig; 1998 Oct; 90(10):687-94. PubMed ID: 9824933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular graft thrombosis after pancreatic transplantation: univariate and multivariate operative and nonoperative risk factor analysis.
    Troppmann C; Gruessner AC; Benedetti E; Papalois BE; Dunn DL; Najarian JS; Sutherland DE; Gruessner RW
    J Am Coll Surg; 1996 Apr; 182(4):285-316. PubMed ID: 8605554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bladder vs enteric drainage in simultaneous pancreas-kidney transplantation.
    Monroy-Cuadros M; Salazar A; Yilmaz S; McLaughlin K
    Nephrol Dial Transplant; 2006 Feb; 21(2):483-7. PubMed ID: 16286430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infectious complications following 72 consecutive enteric-drained pancreas transplants.
    Berger N; Wirmsberger R; Kafka R; Margreiter C; Ebenbichler C; Stelzmueller I; Margreiter R; Steurer W; Mark W; Bonatti H
    Transpl Int; 2006 Jul; 19(7):549-57. PubMed ID: 16764633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary report of a prospective randomized study of octreotide in the treatment of severe acute pancreatitis.
    Paran H; Neufeld D; Mayo A; Shwartz I; Singer P; Kaplan O; Skornik Y; Klausner J; Freund U
    J Am Coll Surg; 1995 Aug; 181(2):121-4. PubMed ID: 7627383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of pancreatic venous drainage site on long-term patient and graft outcome in simultaneous pancreas-kidney transplantation.
    Petruzzo P; Lefrancois N; Berthillot C; Danjou F; Contu P; Codas R; Morelon E; Dubernard JM; Martin X; Badet L
    Clin Transplant; 2008; 22(1):107-12. PubMed ID: 18217911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Octreotide prophylaxis is not beneficial for biochemical activity and clinical severity of postoperative pancreatic fistula after pancreatic surgery.
    Droeser RA; Jeanmonod P; Schuld J; Moussavian MR; Schilling MK; Kollmar O
    Dig Surg; 2012; 29(6):484-91. PubMed ID: 23392293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perioperative treatment with octreotide minimizes technical complications after enteric conversion of bladder-drained pancreas transplants.
    Bogetti D; Nazarewski S; Zieliński A; Sileri P; Testa G; Sankary H; Benedetti E
    Clin Transplant; 2004 Apr; 18(2):137-41. PubMed ID: 15016126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urological complications after simultaneous pancreas-kidney transplantation.
    Medina Polo J; Morales JM; Blanco M; Aguirre JF; Andrés A; Díaz R; Jiménez C; Leiva O; Meneu JC; Moreno E; Pamplona M; Passas J; Rodríguez A; de la Rosa F
    Transplant Proc; 2009; 41(6):2457-9. PubMed ID: 19715950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of 118 pancreas transplants with retroperitoneal portal-enteric drainage.
    Boggi U; Vistoli F; Signori S; Del Chiaro M; Amorese G; Vanadia Bartolo T; Croce C; Sgambelluri F; Marchetti P; Mosca F
    Transplant Proc; 2005; 37(6):2648-50. PubMed ID: 16182774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective comparison of systemic-bladder versus portal-enteric drainage in vascularized pancreas transplantation.
    Stratta RJ; Gaber AO; Shokouh-Amiri MH; Reddy KS; Egidi MF; Grewal HP; Gaber LW
    Surgery; 2000 Feb; 127(2):217-26. PubMed ID: 10686988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twenty-four hour prophylaxis with increased dosage of octreotide reduces the incidence of post-ERCP pancreatitis.
    Thomopoulos KC; Pagoni NA; Vagenas KA; Margaritis VG; Theocharis GI; Nikolopoulou VN
    Gastrointest Endosc; 2006 Nov; 64(5):726-31. PubMed ID: 17055865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.